Article Versions Notes

Flieswasser T, Van Loenhout J, Freire Boullosa L, Van den Eynde A, De Waele J, Van Audenaerde J, Lardon F, Smits E, Pauwels P, Jacobs J. Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer. Cells. 2020; 9(6):1474. https://doi.org/10.3390/cells9061474

Flieswasser, Tal, Jinthe Van Loenhout, Laurie Freire Boullosa, Astrid Van den Eynde, Jorrit De Waele, Jonas Van Audenaerde, Filip Lardon, Evelien Smits, Patrick Pauwels, and Julie Jacobs. 2020. "Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer" Cells 9, no. 6: 1474. https://doi.org/10.3390/cells9061474

Flieswasser, T., Van Loenhout, J., Freire Boullosa, L., Van den Eynde, A., De Waele, J., Van Audenaerde, J., Lardon, F., Smits, E., Pauwels, P., & Jacobs, J. (2020). Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer. Cells, 9(6), 1474. https://doi.org/10.3390/cells9061474